Pinnacle Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Pinnacle Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$435K	Buy	+2,661	New	+$410K	0.02%	278

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pinnacle Wealth Advisors's IBB Position: Q2 2021 in Review

Pinnacle Wealth Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2021: 2,661 shares worth $435K. The stake represents 0.02% of the portfolio and ranks #278 among its holdings.

863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Pinnacle Wealth Advisors held 2,661 shares of iShares Biotechnology ETF worth $435K as of Q2 2021.
iShares Biotechnology ETF was a new Pinnacle Wealth Advisors position in Q2 2021.
iShares Biotechnology ETF made up 0.02% of Pinnacle Wealth Advisors's portfolio in Q2 2021, its #278 holding.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Pinnacle Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.